Table S1 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
<p>AML_Patient_Clinical features</p>
محفوظ في:
| المؤلف الرئيسي: | Emmanuel Griessinger (16721087) (author) |
|---|---|
| مؤلفون آخرون: | Diego Pereira-Martins (16721090) (author), Marielle Nebout (16721093) (author), Claudie Bosc (16721096) (author), Estelle Saland (16446003) (author), Emiline Boet (16721099) (author), Ambrine Sahal (16446000) (author), Johanna Chiche (16721102) (author), Delphine Debayle (16721105) (author), Lucile Fleuriot (16721108) (author), Maurien Pruis (16721111) (author), Véronique De Mas (16721114) (author), François Vergez (15047358) (author), Christian Récher (15047355) (author), Gerwin Huls (16721117) (author), Jean-Emmanuel Sarry (15112165) (author), Jan Jacob Schuringa (16721120) (author), Jean-François Peyron (16721123) (author) |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Table S2 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
حسب: Emmanuel Griessinger (16721087)
منشور في: (2025) -
Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
حسب: Ana Vujovic (15207479)
منشور في: (2025) -
Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
حسب: Ana Vujovic (15207479)
منشور في: (2025) -
Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
حسب: Ana Vujovic (15207479)
منشور في: (2025) -
Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
حسب: Ana Vujovic (15207479)
منشور في: (2025)